This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Ingo Röhl, PhD
Managing Director Analytics at Axolabs


Ingo started his career as Research Associate at the Riedel de Haën AG. He then studied Chemistry and, after completion of his Ph.D. at the University of Oldenburg, worked as Scientist at the Noxxon Pharma AG. Ingo joined Alnyam Europe AG in 2003 where he served as Head of Analytics and built up the analytical department. He held a position as Associate Director at the Roche Kulmbach GmbH and as Senior Director Analytics and Bioanalytics at the Axolabs Kulmbach GmbH before moving to his current role as Managing Director Operations. Ingo has more than 20 years of experience in the field of RNA drug development and (bio-) analytics. He has published more than 20 peer-reviewed articles and book chapters and is inventor on more than 10 patent applications.

Agenda Sessions

  • Optimizing Production of Chemically Modified sgRNA with High Quality